Amicus Therapeutics Us, LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersPhiladelphia, PA
SAM.gov UEIKLJFGENKMD89
Amicus Therapeutics is a wholly owned subsidiary of BioMarin Pharmaceutical Inc. that develops medicines for rare diseases, specifically those that are genetically defined. The company operates in the rare disease biotechnology industry and conducts clinical trials and maintains an expanded access program for its medicines.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Amicus Therapeutics Us, LLC | Philadelphia | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.